Leleu X - Search Results

1

Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients.

Damaj G, Kuhnowski F, Marolleau JP, Bauters F, Leleu X, Yakoub-Agha I. Damaj G, et al. Among authors: leleu x. Eur J Haematol. 2009 Sep;83(3):246-50. doi: 10.1111/j.1600-0609.2009.01259.x. Epub 2009 Mar 19. Eur J Haematol. 2009. PMID: 19302557

2

Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation.

Leleu X, Sendid B, Fruit J, Sarre H, Wattel E, Rose C, Bauters F, Facon T, Jouet J. Leleu X, et al. Bone Marrow Transplant. 1999 Aug;24(4):417-20. doi: 10.1038/sj.bmt.1701898. Bone Marrow Transplant. 1999. PMID: 10467332

3

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy.

Facon T, Avet-Loiseau H, Guillerm G, Moreau P, Geneviève F, Zandecki M, Laï JL, Leleu X, Jouet JP, Bauters F, Harousseau JL, Bataille R, Mary JY; Intergroupe Francophone du Myélome. Facon T, et al. Among authors: leleu x. Blood. 2001 Mar 15;97(6):1566-71. doi: 10.1182/blood.v97.6.1566. Blood. 2001. PMID: 11238092 Free article.

4

Efficacy of a low dose of thalidomide in advanced multiple myeloma.

Leleu X, Magro L, Fawaz A, Bauters F, Facon T, Yakoub-Agha I. Leleu X, et al. Blood. 2002 Aug 15;100(4):1519-20. doi: 10.1182/blood-2002-05-1527. Blood. 2002. PMID: 12184283 Free article. No abstract available.

5

Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma.

Depil S, Leleu X, Micol JB, Berthon C, Laï JL, Bauters F, Quesnel B, Facon T. Depil S, et al. Among authors: leleu x. Leuk Lymphoma. 2004 Dec;45(12):2481-4. doi: 10.1080/10428190412331283224. Leuk Lymphoma. 2004. PMID: 15621764

6

Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).

Leroy H, de Botton S, Grardel-Duflos N, Darre S, Leleu X, Roumier C, Morschhauser F, Lai JL, Bauters F, Fenaux P, Preudhomme C. Leroy H, et al. Among authors: leleu x. Leukemia. 2005 Mar;19(3):367-72. doi: 10.1038/sj.leu.2403627. Leukemia. 2005. PMID: 15674426 Clinical Trial.

7

[Thalidomide: mechanisms of action and new insights in hematology].

Leleu X, Micol JB, Guieze R, Berthon C, Kuhnovsky F, Terriou L, Moreau AS, Yakoub-Agha I, Bauters F, Facon T. Leleu X, et al. Rev Med Interne. 2005 Feb;26(2):119-27. doi: 10.1016/j.revmed.2004.06.017. Rev Med Interne. 2005. PMID: 15710258 Review. French.

8

Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.

Depil S, Mathiot C, Leleu X, Moreau AS, Faucompré JL, Hennache B, Bauters F, Bataille R, Facon T. Depil S, et al. Among authors: leleu x. Br J Haematol. 2005 Jun;129(5):706-7. doi: 10.1111/j.1365-2141.2005.05518.x. Br J Haematol. 2005. PMID: 15916694 Free article. No abstract available.

9

Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.

Leleu X, Le Friec G, Facon T, Amiot L, Fauchet R, Hennache B, Coiteux V, Yakoub-Agha I, Dubucquoi S, Avet-Loiseau H, Mathiot C, Bataille R, Mary JY; Intergroupe Francophone du Myélome. Leleu X, et al. Clin Cancer Res. 2005 Oct 15;11(20):7297-303. doi: 10.1158/1078-0432.CCR-05-0456. Clin Cancer Res. 2005. PMID: 16243800

10

[Treatment of multiple myeloma].

Terriou L, Leleu X, Yakoub-Agha I. Terriou L, et al. Among authors: leleu x. Bull Cancer. 2006 Jan;93(1):101-6. Bull Cancer. 2006. PMID: 16455512 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters